![General FIMRC Fundraiser Graphic Woman taking the blood pressure of another woman at a pop up clinic](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2024/05/General-FIMRC-Fundraiser-Graphic-Twitter-Post.jpg?lossy=1&strip=1&webp=1)
Throughout May, June And July, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To FIMRC
January 12, 2023
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study | Effectiveness of the Bivalent mRNA Vaccine in Preventing Severe COVID-19 Outcomes: An Observational Cohort Study | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection | Increasing Ventilation Reduces Sars-Cov-2 Airborne Transmission In Schools | Use of Carbon Dioxide Monitoring to Assess Ventilation at a National Infectious Diseases Conference
January 5, 2023
Virological characteristics of the SARS-CoV-2 XBB variant | SARS-CoV-2 infection and persistence in the human body | Long-term cardiovascular outcomes of COVID-19 | Heart-disease risk soars | Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants | Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines |
Time to negative PCR conversion among high-risk patients | The Fc-effector function of COVID-19 convalescent plasma | Infectiousness of SARS-CoV-2 breakthrough infections and reinfections
December 29, 2022
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron | Structural brain changes in post-acute COVID-19 patients | Persistent post–COVID-19 smell loss | Persistent symptoms and sequelae after SARS-CoV-2 infection | VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System | Molnupiravir plus usual care versus usual care alone as early treatment for adults | Higher dose corticosteroids in hospitalized COVID-19 patients | FDA approves Roche’s Actemra (tocilizumab) for the treatment of COVID-19 | Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine | Canine real-time detection of SARS-CoV-2 infections | Clinical Validation of a Novel T-Cell Receptor | Modelling the adjustment of COVID-19 response | Two masks can be worse than one: N95 respirator failure caused by an overlying face mask | Airflow Patterns in Double-Occupancy Patient Rooms | The epidemiology of long COVID in US adults
December 22, 2022
Immunological dysfunction persists for 8 months |
Clinical Features and Burden of Post-Acute Sequelae of SARS-CoV-2 Infection |
Demonstration of stable clusters of symptoms | Longitudinal Analysis of T cells in COVID-19 |
Reconsideration of anti-nucleocapsid IgG antibody | Early Estimates of Bivalent mRNA Vaccine |
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated
Hospitalization | Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations |
COVID-19 Convalescent Plasma Outpatient Therapy | Bacterial Co-infection and Empirical Antibiotic Therapy in Patients |
Similar SARS-CoV-2 Ct value distributions in anterior nares versus nasopharyngeal samples |
Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics | The WHO estimates of excess mortality associated with the COVID-19 pandemic |
Impact of SARS-CoV-2 variants on inpatient clinical outcome | Association of Time to Surgery After COVID-19 Infection
December 15, 2022
Progress Toward Poliomyelitis Eradication ― Afghanistan | Moderna Received FDA Emergency Use Authorization For Their Omicron-Targeting Bivalent Covid-19 Booster Vaccine In Children | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons | Authorized Updated (Bivalent) COVID-19 Vaccines for Children | Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster | Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir | The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions | Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
December 8, 2022
SARS-CoV-2 Serology and Self-Reported Infection Among Adults — National Health and Nutrition Examination Survey, United States, August 2021–May 2022 | Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes | Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
| Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants | Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022 | Triage of patients with Ebola virus disease
Situation Dashboards
![World_Health_Organization_logo_logotype World_Health_Organization_logo_logotype](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/World_Health_Organization_logo_logotype-300x89.png?lossy=1&strip=1&webp=1)
![World_Health_Organization_logo_logotype World_Health_Organization_logo_logotype](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/World_Health_Organization_logo_logotype-300x89.png?lossy=1&strip=1&webp=1)
![World_Health_Organization_logo_logotype World_Health_Organization_logo_logotype](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/World_Health_Organization_logo_logotype-300x89.png?lossy=1&strip=1&webp=1)
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
![university-logo-small-horizontal-blue-no-clear-space-51c7fb4524 university-logo-small-horizontal-blue-no-clear-space-51c7fb4524](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/university-logo-small-horizontal-blue-no-clear-space-51c7fb4524-300x57.png?lossy=1&strip=1&webp=1)
![university-logo-small-horizontal-blue-no-clear-space-51c7fb4524 university-logo-small-horizontal-blue-no-clear-space-51c7fb4524](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/university-logo-small-horizontal-blue-no-clear-space-51c7fb4524-300x57.png?lossy=1&strip=1&webp=1)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
![1point3acres 1point3acres](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/1point3acres-300x83.png?lossy=1&strip=1&webp=1)
![1point3acres 1point3acres](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/1point3acres-300x83.png?lossy=1&strip=1&webp=1)
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
![image image](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/image-300x76.png?lossy=1&strip=1&webp=1)
![image image](https://b1663976.smushcdn.com/1663976/wp-content/uploads/2020/03/image-300x76.png?lossy=1&strip=1&webp=1)
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.